Pharma Solutions Platform is a secure, cloud-based Software-as-a-Service (SaaS) solution designed to accelerate clinical trials through smarter imaging and proprietary biomarkers. It supports disease identification and monitoring across a wide range of therapeutic areas, including cardiometabolic, autoimmune, gastrointestinal, and oncological conditions. The platform integrates advanced imaging technologies such as quantitative MRI, DXA, and AI-powered pathology to deliver high-quality, standardized data for clinical decision-making. Pharma Solutions is used globally, with over 1,200 locations, 100+ research partners, and more than 40,000 trial datasets processed. It is backed by extensive clinical validation and peer-reviewed publications.

Features

• Proprietary imaging biomarkers for disease characterization and treatment monitoring.
• Cloud-based SaaS delivery for secure and scalable deployment.
• Multi-organ imaging using quantitative MRI and DXA.
• AI-powered digital pathology for gastrointestinal and oncology trials.
• Body composition analysis for obesity, cancer cachexia, and neuromuscular disorders.
• Integrated reporting workflows for rapid and standardized data processing.
• Support for multiple therapeutic areas, including MASLD/MASH, cirrhosis, autoimmune diseases, and oncology.

Benefits

• Accelerates clinical trials by providing rapid, high-quality imaging data.
• Improves decision-making with validated biomarkers and standardized metrics.
• Reduces trial complexity through integrated multi-organ and pathology analysis.
• Enhances patient stratification and monitoring of treatment response.
• Scalable and secure platform suitable for global deployment.
• Broad clinical applicability across diverse disease areas and trial types.